Dr. Lavik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Pediatric Institute
Cleveland, OH 44195Phone+1 216-445-8048Fax+1 513-636-7905
Education & Training
- Case Western Reserve University School of MedicineClass of 2017
Certifications & Licensure
- OH State Medical License 2017 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Publications & Presentations
PubMed
- 55 citationsA synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting...Andrew R. Lavik, Fei Zhong, Ming-Jin Chang, Edward F Greenberg, Yuvraj Choudhary
Oncotarget. 2015-07-13 - 16 citationsTrends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients.Andrew R Lavik, Osagie Ebekozien, Nudrat Noor, G Todd Alonso, Sarit Polsky
The Journal of Clinical Endocrinology and Metabolism. 2022-06-16 - 20 citationsIdentification of 6-Benzylthioinosine as a Myeloid Leukemia Differentiation–Inducing CompoundDavid N. Wald, Hanna M. Vermaat, Shaolei Zang, Andrew R. Lavik, Zizhen Kang
Cancer Research. 2008-06-01
Press Mentions
- Non-Hispanic Black Patients More Likely to Have Diabetic KetoacidosisApril 13th, 2022
- DKA More Common for Black vs. White People with Type 1 Diabetes Before, During PandemicApril 6th, 2022
- Black People with Diabetes Disproportionately Affected by Diabetic Ketoacidosis During COVIDApril 5th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: